BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21297372)

  • 1. [Current status of researches in genomic medicine and the guidelines for pharmacogenomics (PGx)].
    Kamatani N
    Yakugaku Zasshi; 2011 Feb; 131(2):263-8. PubMed ID: 21297372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Future directions of pharmacogenomics (PGx)].
    Kamatani N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):149-54. PubMed ID: 21941848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.
    Koromina M; Koutsilieri S; Patrinos GP
    Hum Genomics; 2020 Jan; 14(1):4. PubMed ID: 31941550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine: Genetic risk prediction of drug response.
    Zhang G; Nebert DW
    Pharmacol Ther; 2017 Jul; 175():75-90. PubMed ID: 28213088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need to shift pharmacogenetic research from candidate gene to genome-wide association studies.
    Linskey DW; Linskey DC; McLeod HL; Luzum JA
    Pharmacogenomics; 2021 Nov; 22(17):1143-1150. PubMed ID: 34608812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional genomics- and network-driven systems biology approaches for pharmacogenomics and toxicogenomics.
    Yang X; Zhang B; Zhu J
    Curr Drug Metab; 2012 Sep; 13(7):952-67. PubMed ID: 22591344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
    Roses AD
    Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
    Mushiroda T
    Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration.
    Yee SW; Momozawa Y; Kamatani Y; Tyndale RF; Weinshilboum RM; Ratain MJ; Giacomini KM; Kubo M
    Clin Pharmacol Ther; 2016 Nov; 100(5):423-426. PubMed ID: 27256705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics signature: A novel strategy on the individual differences in drug response.
    Guo C; Lin X; Yin J; Xie X; Li J; Meng X; Wu J; Huang L; Huang Z; Yang G; Zhou H; Chen X
    Cancer Lett; 2018 Apr; 420():190-194. PubMed ID: 29432844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association studies in pharmacogenomics: successes and lessons.
    Motsinger-Reif AA; Jorgenson E; Relling MV; Kroetz DL; Weinshilboum R; Cox NJ; Roden DM
    Pharmacogenet Genomics; 2013 Aug; 23(8):383-94. PubMed ID: 20639796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Association Analyses in the Model Rhizobium
    Epstein B; Abou-Shanab RAI; Shamseldin A; Taylor MR; Guhlin J; Burghardt LT; Nelson M; Sadowsky MJ; Tiffin P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics discovery and implementation in genome-wide association studies era.
    Ni X; Zhang W; Huang RS
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):1-9. PubMed ID: 23188748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic identification of pharmacogenomics information from clinical trials.
    Li J; Lu Z
    J Biomed Inform; 2012 Oct; 45(5):870-8. PubMed ID: 22546622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GWAS of Behavioral Traits.
    Mehta D; Czamara D
    Curr Top Behav Neurosci; 2019; 42():1-34. PubMed ID: 31407241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in genomic analysis of stroke: what have we learned and where are we headed?
    Lanktree MB; Dichgans M; Hegele RA
    Stroke; 2010 Apr; 41(4):825-32. PubMed ID: 20167918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomewide Association Studies in Pharmacogenomics.
    McInnes G; Yee SW; Pershad Y; Altman RB
    Clin Pharmacol Ther; 2021 Sep; 110(3):637-648. PubMed ID: 34185318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An association study using imputed whole-genome sequence data identifies novel significant loci for growth-related traits in a Duroc × Erhualian F
    Ji J; Yan G; Chen D; Xiao S; Gao J; Zhang Z
    J Anim Breed Genet; 2019 May; 136(3):217-228. PubMed ID: 30869175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in Pharmacogenomics of Antipsychotic Drug Response.
    Zhang JP; Malhotra AK
    Curr Psychiatry Rep; 2018 Mar; 20(4):24. PubMed ID: 29589131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.